WITHDRAWN: Comparative Safety of Fibrate Drugs: a Pharmacovigilance Study of Fenofibrate and Gemfibrozil
Abstract
Withdrawal Statement The authors have withdrawn this manuscript because We request withdrawal as the current version is incomplete and requires additional experimental data. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.
Fields of Study & Subjects
Pharmacovigilance and Adverse Drug Reactions
Lipoproteins and Cardiovascular Health
Antiplatelet Therapy and Cardiovascular Diseases
Publication details
- Journal / source
- medRxiv
- Publication date
- 2 January 2026
- Document type
- Preprint